John C. Rademacher, Chief Executive Officer, commented, “The Option Care Health team’s execution in a dynamic environment produced another great quarter of results. Overall, we expect 2025 to be a ...

Alternate site health provider Option Care Health (NASDAQ:OPCH) in Q4 CY2024, with sales up 19.7% year on year to $1.35 billion. The company’s full-year revenue guidance of $5.4 billion at the ...

6 analysts have expressed a variety of opinions on Option Care Health (NASDAQ:OPCH) over the past quarter, offering a diverse set of opinions from bullish to bearish. The table below provides a ...

UBS has upgraded Option Care Health (NASDAQ:OPCH) to Buy from Neutral, citing an attractive valuation setup in the infusion services provider following the company’s Q1 2025 results, which exceeded ...

Loomis Sayles, an investment management company, released its “Small Cap Value Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. The first quarter of 2025 saw ...

John C. Rademacher, Chief Executive Officer, commented, “The Option Care Health team’s execution produced solid financial results in the fourth quarter and full year 2024, demonstrating resilience in ...

BANNOCKBURN, Ill., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced the appointment ...

Previous title: Executive vice president and chief financial officer, Littelfuse New title: Executive vice president and chief financial officer, Option Care Health Sethna will assume the head finance ...

It released its preliminary quarterly and full-year 2025 figures. These indicated a healthy year-over-year rise in revenue and a potential bottom-line bump. After market close Monday, Option Care ...

DENVER & BANNOCKBURN, Ill.--(BUSINESS WIRE)--Palantir Technologies Inc. (NYSE: PLTR), a leading provider of AI systems, and Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s ...